December 30, 2025
According to market projections, the generic drugs industry is expected to grow from USD 513.02 billion in 2025 to USD 859.84 billion by 2035, driven by a CAGR of 5.3%, driven by the need to reduce healthcare costs. North America leads the market, wh...
October 17, 2025
According to market projections, the global generic drug CRO market, valued at USD 8.45 billion in 2024, is anticipated to reach USD 11.73 billion by 2034, growing at a CAGR of 3.36% over the next decade. The generic drug CRO market is growing due to...
January 19, 2026
According to market projections, the generic pharmaceuticals sector is expected to grow from USD 460.47 billion in 2025 to USD 1026.8 billion by 2035, reflecting a CAGR of 8.35%. The rise in patent expiration, increasing demand for cost-effective and...
November 04, 2025
According to market projections, the global generic pharmaceuticals contract manufacturing market, valued at USD 81.24 billion in 2025, is anticipated to reach USD 143.22 billion by 2035, growing at a CAGR of 5.85% over the next decade. Day by day, t...
November 01, 2025
According to market estimations the global generic sterile injectable market was estimated at US$ 51.23 billion in 2025 and is projected to grow to US$ 82.14 billion by 2030. In 2023, North America led the market with a 40% share. Monoclonal antibodi...
November 06, 2025
Market insights predict the global inhalation and nasal spray generic drugs industry will increase from USD 25.18 billion in 2025 to USD 59.35 billion by 2035, achieving a CAGR of 8.99%. The inhalation and nasal spray generic drugs market is expandin...
November 01, 2025
According to research analysis, the global Factor Xa inhibitors market, valued at US$ 22.1 billion in 2023, is projected to reach US$ 41.52 billion by 2034, driven by rising cardiovascular diseases. North America leads, while Asia-Pacific shows fas...
February 16, 2026
According to our projections, the API stability testing services market was valued at USD 1.48 billion in 2025 and is projected to reach USD 1.55 billion in 2026, further expanding to USD 2.35 billion by 2035 at a CAGR of 4.74% (2026–2035)....
November 05, 2025
Market insights predict, the branded generics industry is expected to grow from USD 383.1 billion in 2025 to USD 867.21 billion by 2035, driven by a CAGR of 8.47%. The branded generics market is growing due to the rising prevalence of chronic health ...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com